From: Hypomethylation and overexpression of ITGAL (CD11a) in CD4+ T cells in systemic sclerosis
Patients/Age/Sex | SSc subtype | Disease duration | Clinical features | Current treatment | ANA type | MRTSS | SDAI |
---|---|---|---|---|---|---|---|
1/52/F | lcSSc | 2Â years | A, B, R | Prednisone, 10Â mg/day | Nucleolar | 26 | 3.5 |
2/45/M | dcSSc | 2.5Â years | A, E | Prednisone, 12.5Â mg/day | Anti-Scl70 | 33 | 4 |
3/43/F | lcSSc | 3.5Â years | E, M, R | None | ACA | 22 | 2 |
4/45/M | dcSSc | 2.5Â years | M, PF, R | Chinese herbal medicines | Anti-RNP | 25 | 3 |
5/32/F | dcSSc | 0.5Â years | C, R | None | Anti-Scl70 | 14 | 2 |
6/46/F | dcSSc | 1Â years | C, E, R | Prednisone, 7.5Â mg/day | Nucleolar | 39 | 3.5 |
7/49/F | lcSSc | 2.5Â years | A, PF, R | Methylprednisone, 8Â mg/day | Nucleolar | 28 | 4.5 |
8/44/M | dcSSc | 2Â years | A, E | Methylprednisone, 4Â mg/d | Anti-PM-1 | 18 | 2 |
9/47/M | dcSSc | 2Â years | A, B, PF, R | Chinese herbal medicines | Anti-Scl70 | 29 | 5 |
10/37/F | dcSSc | 3Â years | A, B, E, PHT, R | Prednisone, 12.5Â mg/day | Anti-Scl70 | 45 | 9 |
11/39/M | lcSSc | 1.5Â years | E, R | None | none | 21 | 2 |
12/41/F | lcSSc | 2Â years | A, B, E | Prednisone, 15Â mg/day | ACA | 27 | 3.5 |
13/57/F | dcSSc | 2Â years | A, E, PF, R | Prednisone, 12.5Â mg/day | ACA | 40 | 6 |
14/43/M | dcSSc | 2Â years | E, PF, R | None | ACA | 36 | 3 |
15/35/F | dcSSc | 0.5Â years | C, E, R | Prednisone, 7.5Â mg/day | ACA | 22 | 3 |
16/36/M | lcSSc | 2Â years | C, M, R | None | ACA | 19 | 2.5 |
17/40/F | dcSSc | 3Â years | A, E, R | Chinese herbal medicines | Anti-RNP | 22 | 4 |
18/39/M | dcSSc | 2.5Â years | A, E, M, R | None | Nucleolar | 27 | 6 |